Membrane type matrix metalloproteinases (MT-
MMPs) play important roles in malignant
tumor progression through the degradation of the extracellular matrix and signal transduction. However, a member of the family,
MT3-MMP, has attracted the least concern compared with other MT-
MMPs. Here, a novel MT3-MMP-targeting
peptide with high affinity and specificity has been developed by a phage-display
peptide screening technology and multiple biophysics measurements, including single-molecule recognition force spectroscopy and isothermal titration calorimetry. The binding
peptides are conjugated on the surface of CdSe/ZnS
quantum dots (QDs) and consequently acted as a
ligand that specifically targets
MT3-MMP overexpressed
tumor cells. The imaging nanoprobes used QDs as the photographic developer for optical imaging in vivo. The nanoprobes exhibited a desirable targeting effect and generated good biodistribution profiles for visualization and imaging of
MT3-MMP overexpressed
tumor. The
peptide could be useful to evaluate the distribution and expression of
MT3-MMP. Furthermore, the
peptide-functionalized QDs show potential application for
cancer diagnosis.